Europe Colorectal Cancer Diagnostics Market Forecast to 2028

Europe Colorectal Cancer Diagnostics Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Modality [Imaging Tests (Colonoscopy, CT Colonography, Flexible Sigmoidoscopy, Capsule Endoscopy, and Others) and Stool-Based Tests (Faecal Immunochemical Test (FIT), Guaiac-Based Faecal Occult Blood Test, and Stool DNA Test)] and End User (Hospitals, Diagnostic Laboratories, Cancer Research Institutes, and Others)

Send Enquiry
Item ID: BMIRE00028832 Category: Tags: , ,

$2,100$3,500

Description

The Europe colorectal cancer diagnostics market was valued at US$ 3,145.81 million in 2023 and is expected to reach US$ 4,703.52 million by 2028. It is estimated to register a CAGR of 8.4% from 2023 to 2028.

Increasing Prevalence of Colorectal Cancer Drives Europe Colorectal Cancer Diagnostics Market Growth

Colorectal cancer is a malignant tumor that develops in colonic or rectal tissues. As per the data provided by the European Cancer Information System, in EU-27 countries, colorectal cancer accounted for 12.7% of all new cancer diagnoses and 12.4% of total mortalities caused by the disease in 2020. Such a high prevalence makes it the second most frequently occurring cancer, after breast cancer, and the second leading cause of cancer-related deaths, after lung cancer. Surgery is the most common treatment for all stages of colon cancer. In ideal situations, if the cancer is diagnosed in the early stages, doctors can remove the tumor via surgical procedures. A colonoscopy is an important screening test for colorectal cancer diagnostics, and it has become a part of routine cancer screening. Thus, rising prevalence of colorectal cancer drives the growth of the Europe colorectal cancer diagnostics market .

Europe Colorectal Cancer Diagnostics Market Overview

The European colorectal cancer diagnostics market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. In Germany, the colorectal cancer diagnostics market is expected to grow in the coming years due to the rising development in the field of cancer and increasing prevalence of cancer. The National Cancer Plan of the Federal Ministry of Health (Nationaler Krebsplan des Bundesministeriums für Gesundheit) paved the way for the law to develop the cancer detection and quality assurance clinical cancer Registration Act (Gesetz zur Weiterentwicklung der Krebsfrüherkennung und zur Qualitätssicherung durch klinische Krebsregister), which the German parliament approved in 2013. This law prescribes the implementation of organized and quality-assured colon cancer screening programs. In addition, the screening approach for colorectal cancer in the country offers both men and women at least five annual faecal immunochemical tests (FITs) at ages 50–54, followed by a first screening colonoscopy at 55 years in case all of the FITs were negative. On April 4, 2019, a colorectal screening program was organized on the national level, which requires men aged 50 years and women aged 55 years of age to undergo a colonoscopy because of the rise in colorectal cancer risk. The Federal Joint Committee (G-BA) adopted the directive on organized cancer screening programs (oKFE-RL). Colorectal cancer screening was the first organized program to be implemented after that, and starting from July 2019, insured people aged 50 years are regularly invited for screening by health insurance companies. Therefore, the growing prevalence of colorectal cancer and increasing government approaches toward colorectal cancer screening are among the factors driving the Europe colorectal cancer diagnostics market growth.

Europe Colorectal Cancer Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

Europe Colorectal Cancer Diagnostics Market Segmentation

The Europe colorectal cancer diagnostics market is segmented into modality, end user, and country.

Based on modality, the Europe colorectal cancer diagnostics market is bifurcated into imaging tests and stool-based tests. In 2023, the imaging tests segment held a larger share of the Europe colorectal cancer diagnostics market. The market for the imaging tests segment is further segmented into colonoscopy, CT colonography, flexible sigmoidoscopy, capsule endoscopy, and others. The market for the stool based tests segment is subsegmented into faecal immunochemical test (fit), guaiac-based faecal occult blood test (gFOBT), and stool DNA test.

Based on end user, the Europe colorectal cancer diagnostics market is segmented into hospitals, diagnostic laboratories, cancer research institutes, and others. In 2023, the hospitals segment held the largest share of the Europe colorectal cancer diagnostics market.

Based on country, the Europe colorectal cancer diagnostics market is segmented into France, Germany, the UK, Italy, Spain, and the Rest of Europe. In 2023, Germany accounted for the largest share of the Europe colorectal cancer diagnostics market.

Medtronic Plc, Illumina Inc, Epigenomics AG, Novigenix SA, F. Hoffmann-La Roche Ltd, Quest Diagnostics Inc, Siemens Healthineers AG, Bruker Corp, and Eiken Chemical Co., Ltd. are the leading companies operating in the Europe colorectal cancer diagnostics market.

Summary Info

Industry:

Number of pages:

Pricing options:

, ,

Publishing status:

Geographical coverage:

Year of Publication:

At 8.4% CAGR, the Europe Colorectal Cancer Diagnostic Market is speculated to be worth US$ 4,703.52 million by 2028, saysthe research team

According tothe research team’ research, the Europe colorectal cancer diagnostic market was valued at US$ 3,145.81 million in 2023 and is expected to reach US$ 4,703.52 million by 2028, registering a CAGR of 8.4% from 2023 to 2028. Artificial intelligence in colonoscopy and increasing prevalence of colorectal cancer are the critical factors attributed to the Europe colorectal cancer diagnostic market expansion.

The early detection of colorectal cancer (CRC) in gastroenterology offers patients the best opportunity for disease-free and overall survival. However, colonoscopy results show significant variations in lesion detection. The adenoma detection rate (ADR) is the gold standard for evaluating the quality of colonoscopy performed by endoscopists for colorectal cancer screening.

The use of AI technology in diagnosing and treating several types of cancer, especially colorectal cancer, is now gaining substantial attention. Various AI-supporting systems are available for personalized and novel strategies for managing colorectal cancer. In endoscopy, AI broadly relates to a computer vision technology, allowing computers to “see” and interpret visual content. Through machine learning processes and deep learning, AI systems can be trained to recognize “normal” characteristics by linking gold standards to suitable images. Using computer vision for lesion detection will be the first application of AI in gastroenterology. It would help improve the quality of endoscopy practices in finding and recognizing polyps on colonoscopy.

Although AI in colonoscopy is a new field with an extended scope, it can potentially improve the quality of endoscopic examinations and patient care. It can also transform the process of managing performance and quality betterment in colonoscopy, alongside improving several key performance measures. Medtronic has launched its AI-powered GI Genius module for colonoscopy in India. This transformative solution that leans on deep learning algorithms and real-time data empowers physicians to detect and treat colorectal cancer by offering enhanced visualization during colonoscopy. AI applications such as the GI Genius can lead to an improved ADR, facilitating the earlier detection of colorectal cancer, better clinical management of lesions, and detailed characterization of tissues. Thus, the adoption of AI for colorectal cancer imaging tests is likely to bring new trends in the Europe colorectal cancer diagnostics market in the coming years.

On the contrary, low accuracy of screening based on faecal immunochemical tests (FITs) hurdles the growth of Europe colorectal cancer diagnostic market.

Based on modality, the Europe colorectal cancer diagnostics market is bifurcated into imaging tests and stool based tests. The imaging tests segment held 94.1% share of Europe colorectal cancer diagnostic market in 2023, amassing US$ 2,959.81 million. It is projected to garner US$ 4,440.38 million by 2028 to expand at 8.5% CAGR during 2023–2028. The market for the imaging tests segment is further segmented into colonoscopy, CT colonography, flexible sigmoidoscopy, capsule endoscopy, and others. The market for the stool based tests segment is subsegmented into faecal immunochemical test (fit), guaiac-based faecal occult blood test (gFOBT), and stool DNA test.

Based on end user, the Europe colorectal cancer diagnostics market is segmented into hospitals, diagnostic laboratories, cancer research institutes, and others. The hospitals segment held 42.1% share of Europe colorectal cancer diagnostic market in 2023, amassing US$ 1,324.08 million. It is projected to garner US$ 2,029.80 million by 2028 to expand at 8.9% CAGR during 2023–2028.

Based on country, the Europe colorectal cancer diagnostics market is segmented into France, Germany, the UK, Italy, Spain, and the Rest of Europe. Our regional analysis states that Germany captured 26.9% share of Europe colorectal cancer diagnostic market in 2023. It was assessed at US$ 846.79 million in 2023 and is likely to hit US$ 1,296.53 million by 2028, exhibiting a CAGR of 8.9% during the forecast period.

Key players profiles in the Europe colorectal cancer diagnostic market report Medtronic Plc, Illumina Inc, Epigenomics AG, Novigenix SA, F. Hoffmann-La Roche Ltd, Quest Diagnostics Inc, Siemens Healthineers AG, Bruker Corp, and Eiken Chemical Co., Ltd., among others.

– Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific frozen waffles market.
– Highlights key business priorities in order to assist companies to realign their business strategies.
– the key findings and recommendations highlight crucial progressive industry trends in Asia Pacific frozen waffles market, thereby allowing players across the value chain to develop effective long-term strategies.
– develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
– Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the market, as well as those hindering it.
– Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

TABLE OF CONTENTS

1. Introduction
1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 Europe Colorectal Cancer Diagnostics Market – by Modality
1.3.2 Europe Colorectal Cancer Diagnostics Market – by End User
1.3.3 Europe Colorectal Cancer Diagnostics Market – by Country
2. Europe Colorectal Cancer Diagnostics Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Colorectal Cancer Diagnostics Market – Market Landscape
4.1 Overview
4.2 Europe PEST Analysis
4.3 Expert’s Opinion
5. Europe Colorectal Cancer Diagnostics Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Prevalence of Colorectal Cancer
5.1.2 Launches of New Products
5.2 Key Restraints
5.2.1 Low Accuracy of Screening Based on Faecal Immunochemical Tests (FITs)
5.3 Future Trends
5.3.1 Artificial Intelligence in Colonoscopy
5.4 Impact Analysis
6. Colorectal Cancer Diagnostics Market – Europe Analysis
6.1 Europe Colorectal Cancer Diagnostics Market Revenue Forecast and Analysis
7. Europe Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 – by Modality
7.1 Overview
7.2 Europe Colorectal Cancer Diagnostics Market Revenue Share, by Modality 2022 & 2028 (%)
7.3 Stool Based Tests
7.3.1 Overview
7.3.2 Stool Based Tests: Europe Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.3.3 Faecal Immunochemical Test (FIT)
7.3.3.1 Overview
7.3.3.2 Faecal Immunochemical Test (FIT): Europe Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.3.4 Guaiac-based Faecal Occult Blood Test (gFOBT)
7.3.4.1 Overview
7.3.4.2 Guaiac-based Faecal Occult Blood Test (gFOBT): Europe Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.3.5 Stool DNA Test
7.3.5.1 Overview
7.3.5.2 Stool DNA Test: Europe Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Imaging Tests
7.4.1 Overview
7.4.2 Imaging Tests: Europe Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.4.3 Colonoscopy
7.4.3.1 Overview
7.4.3.2 Colonoscopy: Europe Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.4.4 CT Colonography
7.4.4.1 Overview
7.4.4.2 CT Colonography: Europe Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.4.5 Flexible Sigmoidoscopy
7.4.5.1 Overview
7.4.5.2 Flexible Sigmoidoscopy: Europe Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.4.6 Capsule Endoscopy
7.4.6.1 Overview
7.4.6.2 Capsule Endoscopy: Europe Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.4.7 Others
7.4.7.1 Overview
7.4.7.2 Others: Europe Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8. Europe Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 – by End User
8.1 Overview
8.2 Europe Colorectal Cancer Diagnostics Market Revenue Share, by End User 2022 & 2028 (%)
8.3 Hospitals
8.3.1 Overview
8.3.2 Hospitals: Europe Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Diagnostic Laboratories
8.4.1 Overview
8.4.2 Diagnostic Laboratories: Europe Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Cancer Research Institutes
8.5.1 Overview
8.5.2 Cancer Research Institutes: Europe Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Others
8.6.1 Overview
8.6.2 Others: Europe Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9. Europe Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 – Country Analysis
9.1 Overview
9.1.1 Europe: Colorectal Cancer Diagnostics Market, by Country, 2022 & 2028 (%)
9.1.1.1 Germany: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.1.1.1.1 Overview
9.1.1.1.2 Germany: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.1.1.1.3 Germany: Colorectal Cancer Diagnostics Market, by Modality, 2020–2028 (US$ Million)
9.1.1.1.3.1 Germany: Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality, 2020–2028 (US$ Million)
9.1.1.1.3.2 Germany: Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality, 2020–2028 (US$ Million)
9.1.1.1.4 Germany: Colorectal Cancer Diagnostics Market, by End User, 2020–2028 (US$ Million)
9.1.1.2 UK: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.1.1.2.1 Overview
9.1.1.2.2 UK: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.1.1.2.3 UK: Colorectal Cancer Diagnostics Market, by Modality, 2020–2028 (US$ Million)
9.1.1.2.3.1 UK: Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality, 2020–2028 (US$ Million)
9.1.1.2.3.2 UK: Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality, 2020–2028 (US$ Million)
9.1.1.2.4 UK: Colorectal Cancer Diagnostics Market, by End User, 2020–2028 (US$ Million)
9.1.1.3 France: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.1.1.3.1 Overview
9.1.1.3.2 France: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.1.1.3.3 France: Colorectal Cancer Diagnostics Market, by Modality, 2020–2028 (US$ Million)
9.1.1.3.3.1 France: Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality, 2020–2028 (US$ Million)
9.1.1.3.3.2 France: Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality, 2020–2028 (US$ Million)
9.1.1.3.4 France: Colorectal Cancer Diagnostics Market, by End User, 2020–2028 (US$ Million)
9.1.1.4 Italy: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.1.1.4.1 Overview
9.1.1.4.2 Italy: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.1.1.4.3 Italy: Colorectal Cancer Diagnostics Market, by Modality, 2020–2028 (US$ Million)
9.1.1.4.3.1 Italy: Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality, 2020–2028 (US$ Million)
9.1.1.4.3.2 Italy: Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality, 2020–2028 (US$ Million)
9.1.1.4.4 Italy: Colorectal Cancer Diagnostics Market, by End User, 2020–2028 (US$ Million)
9.1.1.5 Spain: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.1.1.5.1 Overview
9.1.1.5.2 Spain: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.1.1.5.3 Spain: Colorectal Cancer Diagnostics Market, by Modality, 2020–2028 (US$ Million)
9.1.1.5.3.1 Spain: Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality, 2020–2028 (US$ Million)
9.1.1.5.3.2 Spain: Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality, 2020–2028 (US$ Million)
9.1.1.5.4 Spain: Colorectal Cancer Diagnostics Market, by End User, 2020–2028 (US$ Million)
9.1.1.6 Rest of Europe: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.1.1.6.1 Overview
9.1.1.6.2 Rest of Europe: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.1.1.6.3 Rest of Europe: Colorectal Cancer Diagnostics Market, by Modality, 2020–2028 (US$ Million)
9.1.1.6.3.1 Rest of Europe: Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality, 2020–2028 (US$ Million)
9.1.1.6.3.2 Rest of Europe: Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality, 2020–2028 (US$ Million)
9.1.1.6.4 Rest of Europe: Colorectal Cancer Diagnostics Market, by End User, 2020–2028 (US$ Million)
10. Europe Colorectal Cancer Diagnostics Market–Industry Landscape
10.1 Overview
10.2 Inorganic Growth Strategies
10.2.1 Overview
10.3 Organic Growth Strategies
10.3.1 Overview
11. Company Profiles
11.1 Medtronic Plc
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 Illumina Inc
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Epigenomics AG
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 F. Hoffmann-La Roche Ltd
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 Quest Diagnostics Inc
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 Novigenix SA
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Products and Services
11.6.4 Financial Overview
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 Siemens Healthineers AG
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Products and Services
11.7.4 Financial Overview
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 Bruker Corp
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Products and Services
11.8.4 Financial Overview
11.8.5 SWOT Analysis
11.8.6 Key Developments
11.9 Eiken Chemical Co., Ltd.
11.9.1 Key Facts
11.9.2 Business Description
11.9.3 Products and Services
11.9.4 Financial Overview
11.9.5 SWOT Analysis
11.9.6 Key Developments
12. Appendix
12.1 About
12.2 Glossary of Terms

LIST OF TABLES

Table 1. Europe Colorectal Cancer Diagnostics Market –Revenue and Forecast to 2028 (US$ Million)
Table 2. Screening approach for colorectal cancer followed in Germany is mentioned in the given Table:
Table 3. Germany Colorectal Cancer Diagnostics Market, by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 4. Germany Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 5. Germany Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 6. Germany Colorectal Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 7. UK Colorectal Cancer Diagnostics Market, by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 8. UK Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 9. UK Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 10. UK Colorectal Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 11. France Colorectal Cancer Diagnostics Market, by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 12. France Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 13. France Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 14. France Colorectal Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 15. Italy Colorectal Cancer Diagnostics Market, by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 16. Italy Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 17. Italy Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 18. Italy Colorectal Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 19. Spain Colorectal Cancer Diagnostics Market, by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 20. Spain Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 21. Spain Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 22. Spain Colorectal Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 23. Rest of Europe Colorectal Cancer Diagnostics Market, by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 24. Rest of Europe Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 25. Rest of Europe Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 26. Rest of Europe Colorectal Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 27. Recent Inorganic Growth Strategies in the Europe colorectal cancer diagnostics market
Table 28. Recent Organic Growth Strategies in the Europe colorectal cancer diagnostics market
Table 29. Glossary of Terms

LIST OF FIGURES

Figure 1. Europe Colorectal Cancer Diagnostics Market Segmentation
Figure 2. Europe Colorectal Cancer Diagnostics Market, by Country
Figure 3. Europe Colorectal Cancer Diagnostics Market Overview
Figure 4. Imaging Tests Segment Held Largest Share of Modality Segment in Europe Colorectal Cancer Diagnostics Market
Figure 5. France Expected to Show Remarkable Growth During Forecast Period
Figure 6. Europe: PEST Analysis
Figure 7. Experts’ Opinion
Figure 8. Europe Colorectal Cancer Diagnostics Market Impact Analysis of Driver and Restraints
Figure 9. Europe Colorectal Cancer Diagnostics Market – Revenue Forecast and Analysis – 2020- 2028
Figure 10. Europe Colorectal Cancer Diagnostics Market Revenue Share, by Modality 2022 & 2028 (%)
Figure 11. Stool Based Tests: Europe Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. Faecal Immunochemical Test (FIT): Europe Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. Guaiac-based Faecal Occult Blood Test (gFOBT): Europe Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. Stool DNA Test: Europe Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. Imaging Tests: Europe Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. Colonoscopy: Europe Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. CT Colonography: Europe Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. Flexible Sigmoidoscopy: Europe Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. Capsule Endoscopy: Europe Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. Others: Europe Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Europe Colorectal Cancer Diagnostics Market Revenue Share, by End User 2022 & 2028 (%)
Figure 22. Hospitals: Europe Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. Diagnostic Laboratories: Europe Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. Cancer Research Institutes: Europe Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. Others: Europe Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. Europe: Colorectal Cancer Diagnostics Market, by Key Country – Revenue (2022) (US$ Million)
Figure 27. Europe: Colorectal Cancer Diagnostics Market, by Country, 2022 & 2028 (%)
Figure 28. Germany: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 29. UK: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 30. France: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 31. Italy: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 32. Spain: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 33. Rest of Europe: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

The List of Companies – Europe Colorectal Cancer Diagnostics Market
– Bruker Corp
– Eiken Chemical Co., Ltd.
– Epigenomics AG
– F. Hoffmann-La Roche Ltd
– Illumina Inc
– Medtronic Plc
– Novigenix SA
– Quest Diagnostics Inc
– Siemens Healthineers AG

Reviews

There are no reviews yet.

Be the first to review “Europe Colorectal Cancer Diagnostics Market Forecast to 2028”